CNTNAP2 and schizophrenia: CNTNAP2 was curated by ClinGen in 2019 (HI score of 1), highlighting its emerging association with autosomal dominant complex neurodevelopmental disorders, including ID, DD, epilepsy, schizophrenia, Tourette syndrome, and increased susceptibility to autism [30,31,32,33].